Cel Sci CVM
NYSE CVM
$1.78 +0.08 (+4.90%)
As of: Sep 29, 2026 · 3:58 PM EDT

Cel Sci (CVM) Debt Ratio (2017 - 2018)

Updated

Cel Sci's Debt Ratio came in at 0.05 for fiscal Q2 2018 (quarter ended Mar 31, 2018), up 29.2% from the prior quarter.

Analysis

Cel Sci (CVM) Debt Ratio (2017 - 2018) Analysis & Trends

For FY2017 (ended Sep 30, 2017), Cel Sci's Debt Ratio was 0.04.

  • Business Quant data shows CVM's Debt Ratio at 0.04 (Q1 2018), 0.04 (Q4 2017) and 0.01 (Q3 2017) in the three fiscal quarters before Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Cel Sci 3.11 Mn -22.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 0.05
Dec 31, 2017 0.04
Sep 30, 2017 0.04
Jun 30, 2017 0.01
API Access

Cel Sci Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CVM&period=max&api_key=YOUR_API_KEY